New study tests smart insulin pumps and training to restore low blood sugar warning signs
NCT ID NCT06325202
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether combining automated insulin pumps (Omnipod 5 or Medtronic 780G) with specialized education can help adults with type 1 diabetes who have lost the ability to feel low blood sugar (hypoglycemia). The trial will enroll 324 participants and follow them for up to 24 months, measuring hormone responses and symptom awareness. The goal is to restore the body's natural warning system for dangerously low glucose levels.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Omnipod 5 or Medtronic 780G automated insulin delivery system, plus My HypoCOMPaSS or HARPdoc education program
What this could lead to
If successful, this could help people with type 1 diabetes regain the ability to sense low blood sugar, reducing dangerous episodes and improving daily safety.
What could go wrong
This is a mid-sized study, not a cure. Results may vary, and the education programs may not work for everyone. The devices require ongoing use and management.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 1 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
AdventHealth
RECRUITINGOrlando, Florida, 32804, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of California, San Diego
RECRUITINGLa Jolla, California, 92037, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of Kentucky
RECRUITINGLexington, Kentucky, 40508, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of Leicester
RECRUITINGLeicester, LE5 4PW, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of Melbourne
RECRUITINGFitzroy, Victoria, 3065, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Minnesota
RECRUITINGMinneapolis, Minnesota, 55455, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Pennsylvania
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of Sheffield
RECRUITINGSheffield, S10 2RX, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact